Advinus Therapeutics Ltd - Product Pipeline Review - 2016

  • ID: 3783282
  • Company Profile
  • 42 pages
  • Global Markets Direct
1 of 3
Advinus Therapeutics Ltd - Product Pipeline Review - 2016

Summary

‘Advinus Therapeutics Ltd - Product Pipeline Review - 2016’, provides an overview of the Advinus Therapeutics Ltd’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Advinus Therapeutics Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Our report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Advinus Therapeutics Ltd
- The report provides overview of Advinus Therapeutics Ltd including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Advinus Therapeutics Ltd’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Advinus Therapeutics Ltd’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Advinus Therapeutics Ltd’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Advinus Therapeutics Ltd
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Advinus Therapeutics Ltd’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 3
List of Tables

List of Figures

Advinus Therapeutics Ltd Snapshot

Advinus Therapeutics Ltd Overview

Key Information

Key Facts

Advinus Therapeutics Ltd - Research and Development Overview

Key Therapeutic Areas

Advinus Therapeutics Ltd - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Advinus Therapeutics Ltd - Pipeline Products Glance

Advinus Therapeutics Ltd - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Advinus Therapeutics Ltd - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Advinus Therapeutics Ltd - Drug Profiles

GKM-001

Product Description

Mechanism of Action

R&D Progress

Small Molecule for Type 2 Diabetes

Product Description

Mechanism of Action

R&D Progress

PNQ-103

Product Description

Mechanism of Action

R&D Progress

PNQ-201

Product Description

Mechanism of Action

R&D Progress

PNQ-370

Product Description

Mechanism of Action

R&D Progress

PNQ-849

Product Description

Mechanism of Action

R&D Progress

Small Molecule for Visceral Leishmaniasis

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit FAAH for Chemotherapy Induced Peripheral Neuropathy

Product Description

Mechanism of Action

R&D Progress

PNQ-154

Product Description

Mechanism of Action

R&D Progress

PNQ-401

Product Description

Mechanism of Action

R&D Progress

PNQ-701

Product Description

Mechanism of Action

R&D Progress

Small Molecule for Leishmaniasis

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Agonize GPR40 and GPR120 Receptors for Type 2 Diabetes

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Antagonize GPR40 for Obesity

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Antagonize GPR91 for Retinal Angiogenesis and Liver Fibrosis

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Antagonize RAR-Related Orphan Receptor Gamma for Psoriasis

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit BTK for Inflammation, Autoimmune Disorders and Cancer

Product Description

Mechanism of Action

R&D Progress

Advinus Therapeutics Ltd - Pipeline Analysis

Advinus Therapeutics Ltd - Pipeline Products by Target

Advinus Therapeutics Ltd - Pipeline Products by Route of Administration

Advinus Therapeutics Ltd - Pipeline Products by Molecule Type

Advinus Therapeutics Ltd - Pipeline Products by Mechanism of Action

Advinus Therapeutics Ltd - Recent Pipeline Updates

Advinus Therapeutics Ltd - Dormant Projects

Advinus Therapeutics Ltd - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Advinus Therapeutics Ltd, Key Information

Advinus Therapeutics Ltd, Key Facts

Advinus Therapeutics Ltd - Pipeline by Indication, 2016

Advinus Therapeutics Ltd - Pipeline by Stage of Development, 2016

Advinus Therapeutics Ltd - Monotherapy Products in Pipeline, 2016

Advinus Therapeutics Ltd - Partnered Products in Pipeline, 2016

Advinus Therapeutics Ltd - Partnered Products/ Combination Treatment Modalities, 2016

Advinus Therapeutics Ltd - Phase II, 2016

Advinus Therapeutics Ltd - Preclinical, 2016

Advinus Therapeutics Ltd - Discovery, 2016

Advinus Therapeutics Ltd - Pipeline by Target, 2016

Advinus Therapeutics Ltd - Pipeline by Route of Administration, 2016

Advinus Therapeutics Ltd - Pipeline by Molecule Type, 2016

Advinus Therapeutics Ltd - Pipeline Products by Mechanism of Action, 2016

Advinus Therapeutics Ltd - Recent Pipeline Updates, 2016

Advinus Therapeutics Ltd - Dormant Developmental Projects,2016

Advinus Therapeutics Ltd, Other Locations

List of Figures

Advinus Therapeutics Ltd - Pipeline by Top 10 Indication, 2016

Advinus Therapeutics Ltd - Pipeline by Stage of Development, 2016

Advinus Therapeutics Ltd - Monotherapy Products in Pipeline, 2016

Advinus Therapeutics Ltd - Partnered Products in Pipeline, 2016

Advinus Therapeutics Ltd - Pipeline by Top 10 Target, 2016

Advinus Therapeutics Ltd - Pipeline by Route of Administration, 2016

Advinus Therapeutics Ltd - Pipeline by Molecule Type, 2016

Advinus Therapeutics Ltd - Pipeline Products by Top 10 Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll